Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Gilead Sciences
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Collaboration will leverage Onko-Innate’s deep expertise in NK Cell Tumor Biology to discover novel therapies in immuno-oncology and cell therapy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 21, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Gilead Sciences
Deal Size : Undisclosed
Deal Type : Collaboration